We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Thursday, 6 February 2020, highlighting Roche data on risdiplam in type 2/3 spinal muscular atrophy from the SUNFISH Part 2 trial presented at the 2nd International Scientific Congress on Spinal Muscular Atrophy, (5 - 7 Feb) in Evry, France.

Please dial in as outlined below:
15:00 - 15:45 CET / 14:00 - 14:45 GMT
09:00 - 09:45 am EST / 06:00 - 06:45 am PST

Audio webcast and conference call will start with presentations followed by a Q&A session (live access to the speakers).

Access to Audio webcast
 Please access by clicking on >ir.roche.com

Access to Conference Call (pre-registration required)
You will receive phone numbers, passcode and your personal PIN to direct access the conference call by pre-registering here.

Should you have any issues with the registration, please dial the following numbers on the day of the conference call 10-15 minutes prior to conference start:

+41 (0) 58 310 50 00 (Europe & RoW)
+44 (0) 207 107 0613 (UK)
+1 631 570 56 13 (USA)

A replay of the webcast will be available via >ir.roche.com

Attachments

  • Original document
  • Permalink

Disclaimer

Roche Holding AG published this content on 17 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 January 2020 09:13:00 UTC